Introduction: Annona muricata and Tapinanthus globiferus (mistletoe) are medicinal plants used in traditional medicine to combat an array of human diseases. However, there is dearth of scientific prove for the activity of these plants in the management of non-infectious human diseases such as cancer, insomnia, hypertension, ulcers and diabetes. Method: The present study was designed to assess comparatively the effects of methanol extracts of Annona muricata (AME) and Tapinanthus globiferus (TGE) on biochemical indices of alloxan induced diabetic rats. The animals were allocated to eight (8) groups, group I were normal non-diabetic rats, group II (diabetic untreated group), group III treated with metformin alone, groups IV & V were diabetic rats treated with AME at dose of concentration 200 mg/kg BW & 400 mg/kg BW respectively, groups VI & VII were diabetic rats treated with 200 mg/kg BW & 400 mg/kg BW of TGE respectively. Group VIII were diabetic rats treated with AME + TGE at concentration of 200 mg/kg BW each. Concentrations of serum total cholesterol (TC), high density lipoprotein (HDL), triglyceride (TG) of alloxan diabetic rats, creatinine and urea were assayed after 21 days of the respective treatments. Results: Diabetic untreated rats had significant increase p<0.05 in TC, TG, urea and creatinine compared to normal control group as opposed to the significant decrease observed for HDL in diabetic rats. However, treatment of diabetic rats with AME and TGE significantly suppressed (p<0.05) the concentrations of TC, TG and creatinine when compared with the diabetic untreated rats. A similar trend was observed for the calculated atherogenic index of treated rats when compared with diabetic untreated rats. Interestingly, co-administration of AME + TGE improved the biochemical indices of diabetic rats better than using each plant separately. Conclusion: The results of this study suggest that AME and TGE could offer some benefits in the management of diabetic complications especially with regard to cardiac and renal health.
INTRODUCTION
Diabetes mellitus is the most common metabolic disorder of the endocrine system. It is characterised by defects in insulin secretion or insensitivity of insulin receptors categorized as type I and type II diabetes respectively. 1 Either of these metabolic anomalies is characterised by impaired metabolism of carbohydrates and other energy-yielding fuel compounds such as lipids and proteins. This results in diabetic complications including but not limited to hyperglycemia, retinopathy, dyslipidemia, and nephropathy. 2 The prevalence of diabetes and its complications is on the increase in part due to changes in life style. It is projected that by the year 2030, over 500 million adults will be affected by diabetes mellitus. 3 The projected increase in prevalence is expected to be higher in Africa and Asia where there is rapid epidemiological transition. Treatment measures currently available for diabetes include orthodox drugs, diet control, exercise and the use of medicinal plants. Medicinal plants seem to be gaining acceptance for the management of diabetes due its fewer side effects compared to orthodox drugs. Medicinal plants contain phytochemicals that have been a pivotal pipeline for drug discovery. 4 In Nigeria, there are claims that Annona muricata and Tapinanthus globiferus have anti-diabetic properties. Annona muricata is a fruit tree of the Annonaceae family also known by the names soursop, graviola and guanabana. 5 Communities in Africa and South America use this plant for medicinal purposes. Use of Annona muricata for the treatment of malaria, hepatoprotection, prostate enlargment and diabetes has been scientifically substantiated. These pharmacological properties can be attributed to the abundance of phytochemicals such alkaloids, megastigmanes, triglycosides, flavonoid, phenolics, cyclopetide and essential oils in Annona muricata. 6, 7 These phytochemicals are believed to confer various medicinal properties on plants. Tapinanthus globiferus, a mistletoe is of the family Loranthacea native to Nigeria and Cameroon. Tapinanthus globiferus is commonly consumed for the treatment of hypertension, ulcers, poor vision, and diabetes and for promoting muscular relaxation. 8 Experimental evidence reveals that Tapinanthus globiferus possess a variety of pharmacological activities. Adekunle et al., showed that Tapinanthus globiferus extracts possessed anti-inflammatory properties evidenced by marked reduction in serum levels of TNF-α and IL-2 in animals. 9 They also reported that Tapinanthus globiferus reduced lipid peroxidation in acetaminophen induced oxidative stress rat model. 9 In a similar experiment by Abubakar et al., the stimulatory effect of Tapinanthus globiferus on antioxidant enzymes in rats was reported. 10 These pharmacological benefits could be explained by the rich antioxidant contents evidenced by the ability to scavenge free radicals and inhibit lipid peroxidation. 11 Therefore, the present study was designed to compare the benefits of the two plants in combating the complications of diabetes on one hand, and on the other hand establish the benefits or otherwise of the combination of both plants.
MATERIALS AND METHODS

Plant collection and extraction
Fresh young leaves of Annona muricata and Tapinanthus globiferus plants were collected in the month of June from Anyigba, Kogi State, Nigeria. The leaves were dried until constant weight was achieved and thereafter pulverized. Extraction of pulverized leaves was done with methanol at room temperature for 2 days in accordance with previously published studies but minor modifications. 12, 13 The filtrate was concentrated in a rotary evaporator.
Laboratory animals
Forty eight (48) male albino rats weighing between 180 -200 g were used for this study. The animals were maintained in appropriate laboratory conditions (25 ± 3°C temperature and 12-hr dark-12-hr light cycle) and fed rat chow and water ad libitum.
Induction of diabetes and experimental design
Diabetes was induced by a single intraperitoneal injection of freshly prepared alloxan monohydrate at a dose of 150 mg/kg BW. After two (2) days blood was taken from the tail through a lancet cut and blood glucose levels were measured using a Glucometer. Rats with fasting blood glucose levels ≥ 250 mg/dl were considered to be diabetic. Normal non-diabetic rats were used as control (group I). The diabetic rats were randomly assigned to seven (7) groups as follows: Diabetic untreated (group II), Metformin treatment (group III), Annona muricata 200 mg/kg BW treatment (group IV), Annona muricata 400 mg/kg BW treatment (group V), Tapinanthus globiferus 200 mg/kg BW treatment (group VI), Tapinanthus globiferus 400 mg/kg BW treatment (group VII), diabetic rats receiving Annona muricata + Tapinanthus globiferus 200mg/kg BW each (group VIII). The treatments were administered once a day for 21 days. The concentrations of plant extracts and drugs used in this study are similar to safe and effective doses used in earlier studies. 5, 14 Biochemical tests On the 22 nd day being the day after the last treatment, animals were sacrificed and blood was collected. Serum was prepared from whole by a low speed centrifugation at 3, 000 rpm for 10 minutes. Blood lipids namely, TC, HDL and TG and markers of kidney damage namely, creatinine and urea were estimated using Randox diagnostic kits according to the manufacturer's protocols. Atherogenic index was calculated according to the method of Ojiako et al., using the formula 15 :
Data analysis
Results were expressed as Means ± SD. Differences among experimental groups were analyzed by Analysis of Variance (ANOVA) using SPSS 16.0. Differences among groups were considered significant when p< 0.05.
RESULTS AND DISCUSSION
This study was designed to compare the benefits of methanol extracts of Annona muricata and Tapinanthus globiferus in the management of dyslipidemia and nephropathy using the alloxan diabetes rat model. Alloxan induces insulin dependent diabetes through reactive oxygen species (ROS) mediated destruction of pancreatic β-cells leading to hyperglycemia and derangement of several metabolic pathways. 16 Administration of alloxan at dose of 150 mg/kg BW caused significant alterations in the lipid profile and indices of kidney function in conformity with earlier studies which utilised alloxan for creating animal models of hyperlipidemia and nephropathy. 7, 14 Figure 1 shows the effects of AME and TGE on the lipid profile of diabetic rats. AME and TGE caused a dose dependent reduction of the levels of TC when compared with diabetic untreated rats whose TC levels were elevated by alloxan. In fact, AME at 400 mg/kg BW produced a reduction of TC commensurate to the standard anti-diabetic drug metformin. The reduction was however, more pronounced in the group treated with AME than in the TGE group. A similar trend was observed in the TG levels of AME and TGE treated diabetic rats when compared with the negative control. These results are in consonance with available published evidence on the antihyperlipidemic, anti-hyperglycaemic potentials of AME and TGE. 5, 17, 18 In other related works it was reported that AME and TGE could protect serum and brain lipids from peroxidation through the enhancement of antioxidant enzyme levels. [10] [11] [12] [13] [14] [15] [16] [17] [18] The most common lipid abnormalities in diabetes are hypertriglyceridemia and hypercholesterolemia. The increase in the levels of serum levels of cholesterol and triglycerides in the diabetic rats is a result of insulin deficiency and altered activity of enzymes such as lipases and lecithin cholesterol acyl transferase (LCAT) for regulation of blood lipids. Indeed, there is evidence to show that AME stimulates the release of insulin and restoration of pancreatic cells which could be responsible for the reversal of hyperlipidaemia. 5, 13, 18 Attenuation of the alteration in levels of serum lipids reveals that AME and TGE have anti-hyperlipidaemia properties that could protect against cardiovascular complications. Decreased serum levels of TC could be attributed to increased fecal excretion of cholesterol or decreased activity of 3-hydroxy-3-methylglutarylcoenzyme (HMG-CoA) reductase and acyl CoA cholesterol acyltransferase (ACAT). Conversely, the concentrations of HDL declined upon induction of diabetes with alloxan. The inverse relationship between TG and HDL has been established by existing literature. AME and TGE ameliorated the decline in serum HDL levels; AME at 400 mg/kg BW was the most effective with its potency comparable to the standard anti-diabetic drug metformin. High levels of HDL connote an improved cardiovascular health because HDL is responsible for removal of cholesterol from the blood through a mechanism known as reverse cholesterol transport.
The calculated atherogenic index (AI) is a measure of predisposition of animals to developing atherosclerosis; high AI signifies a tendency to develop atherosclerosis. Obviously, there was escalation of AI about thirty (30) folds in diabetic untreated rats when compared to normal control rats (Table 1) . Rats treated with AME and TGE however, showed promising reduction in AI, this corroborates the studies of Agbai et al. in which AME increased the anti-atherogenic index of diabetic rats evidenced by reduction in the aortic wall thickening. 19 Morbidity and mortality resulting from diabetic nephropathy is common among diabetic patients. Its symptoms include increased catabolism of proteins, altered glomerular filtration and hike in the concentrations of creatinine, urea and electrolyte concentrations. In the present study creatinine and urea were assayed in order to access the kidney function. Creatinine and urea serum levels drastically increased in diabetic rats which were decreased by treatment with AME and TGE as shown in Figure 2 . Again, AME proved to be more efficacious than TGE in managing the kidney function indices of diabetic rats. These evidences are supported by other works where AME lowered the upswing in serum electrolytes and other markers of kidney damage. 18, 20 Although it is not clear the reason for the elevated creatinine levels of rats in Group VI treated with 200 mg/kg BW of TGE. A plausible explanation could be increased muscle degradation leading to elevated serum levels of creatinine.
Overall, combinations of AME + TGE provided prove of principle that co-administration of medicinal products could offer some synergistic or additive effects. Interestingly, in the present study, the group treated with both AME and TGE had improved biochemical indices than the groups treated with a single plant. There have been similar results from efforts of scientists to treat diabetes with combination of two or more plants. 15, 21 For instance combinations of Tapinanthus globiferus + Treculia africana and Annona muricata + Artocarpus heterophyllus were more potent at arresting diabetic nephropathy, hyperglycemia and hyperlipidemia than any of the plants used alone. 14, 20 In summary, the results here presented could be attributed to the positive effects of the phytochemical components of the extracts used for this study. This assertion is buttressed by the works of Nguegium et al. and Ogunbolude et al. which showed that AME and TGE are rich in bioactive phytochemicals which are known to have several health benefits including the management of diabetes and other metabolic diseases. 18, 22 
